NCT07802509Recruiting
Does Hippotherapy Have an Effect on Mobility, Gait, Balance and Perceived Health-related Quality of Life in Persons With Parkinson's Disease?
Source: ClinicalTrials.gov · Last updated 17 Sept 2026
Brief summary (registry, in English)
The goal of this pilot randomized controlled trial is to investigate the effects of hippotherapy (horse assisted therapy) (intervention group) compared to usual care (control group) on mobility, gait, balance and perceived health-related quality of life in persons with Parkinson's disease. The main objectives of this study are: * The primary objective is to investigate the effects of hippotherapy on mobility of pwPD, walking speed and the ability to perform daily movements. * The secondary objective is to investigate the effects of hippotherapy on (a) balance, (b) self-perceived physical and mental health and (c) specific gait parameters. * Furthermore this study, aims to gather critical information that will inform about the design and implementation of a larger, more definitive randomized controlled trial. In addition to the three-week, multidisciplinary rehabilitation program the intervention group will receive hippotherapy (20 minutes) three times a week (7 sessions in total) and the control group will receive additional physiotherapy sessions (30 minutes) two times a week.
- Status (registry)
- Recruiting
- Study type
- Interventional
- Enrollment
- 30 (estimated)
- First submitted
- 31 Aug 2026
- Start date
- 1 Jan 2025
- Primary completion date
- 1 Jan 2027
- Lead sponsor
- Klinik Valens
- Diseases
- Parkinson disease
- NCT number
- NCT07802509
What you commit to
- Study type: Interventional
- Planned participants: 30
- From 1 Jan 2025 to the primary completion date, 1 Jan 2027
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Severe cognitive impairment, defined by a score below 26 on the Montreal Cognitive Assessment (MoCa)
- Horse hair allergy;
- Other acute and subacute cardiovascular, respiratory, musculoskeletal or neurological disorders that constitute a contraindication to hippotherapy (i.e. a recent fracture);
Other
- Body weight \> 90kg;
- Pregnancy.
Who the study is looking for
- Confirmed diagnosis of Parkinson's diagnosis
- Age \> 18 Years;
- Hoehn \& Yahr stage ≤ 4;
- Category 3 in the Functional Ambulation Categories
- Climbing stairs is possible (with support).
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Rehabilitation Centre Valens Coordinator of this site? Confirm its status | Valens | Switzerland | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.